Cargando…
A real-world experience of second-line nivolumab in mesothelioma patients during the COVID-19 pandemic
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V. Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8159462/ http://dx.doi.org/10.1016/S0169-5002(21)00276-2 |
Sumario: |
---|